NFKB1 and neoplasm: IL-23 then activates IL-17A, IL-6, and IL-22 production (71, 75, 76), eventually promoting tumor cell proliferation by activating nuclear factor-κB (NF-κB) and STAT3 signaling pathway (77, 78).